Share

Acute Urinary Retention And BPH-Related Surgery: Predicting Those At Highest Risk And Prevention With Finasteride

This research involved 3,040 men with symptoms of benign prostatic hyperplasia (BPH), or enlarged prostate, who enrolled in a four-year, double-blind, placebo-controlled protocol. The investigators were studying the use of a drug, finasteride, in BPH to lower the incidence of either acute urinary retention or a surgical procedure over the four-year period. According to the researchers, patients with moderate to severe symptoms and PSA test levels above 1.3 ng/ml were at increased risk of either acute retention or surgery. They noted that finasteride markedly reduced the risk of these outcomes by approximately 50% in all subgroups over the four-year period.

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.